READING ROOM · CORRESPONDENCE
Contact TB-500 Telehealth
For corrections, citation feedback, or general editorial questions about the TB-500 and thymosin beta-4 research literature covered on this site.
Editorial Correspondence
Correspondence is welcome on the record itself: a factual correction, a peer-reviewed study or registered trial to add, or a citation query for the full source behind a numbered reference. Those notes are read and considered. This is a reading room and not a waiting room — it cannot schedule a visit, advise on dosing or treatment, help you obtain or import the peptide, or recommend a vendor or product. Requests of that kind fall outside its editorial scope and are not answered.
Contact Form
A contact form sits below for written notes. Name the page and passage you mean and keep the message brief; quote the numbered reference where a source is in question. Substantive editorial mail is answered within about ten business days as volume allows. Sending it is not a request for medical, legal, or commercial service and opens no professional relationship with the publisher.